VitalCare’s “Patient
Of The Month” Program Launch
Former Hunter-Killer Team Commander of 101st
Airborne “Screaming Eagles”
Testimony
CARSON CITY, Nev. (Business Wire EON/PRWEB ) June 19, 2008 --
VitalCare Diabetes Treatment Centers, Inc. (Pinks Sheets: VDTI),
today announces the first personal testimony about iCAT Therapy on the
Company’s website under the section titled, “Patient
of the Month”.
“We are very excited to have an opportunity to
share the personal testimonies from patients who are currently receiving
iCAT Therapy or who have received iCAT therapy and would like to share
their experience with us,” says Jimmy A.
McDougald, CEO and Co-founder of VitalCare.
Learn how this former US Army Helicopter “Hunter-Killer”
Team Commander of the 101st Airborne “Screaming
Eagles” was medically discharged from the US
Army due to his undiagnosed diabetes. Read his personal testimony, how
this US Army officer was grounded by diabetes, effectively ending his
military career, how he began to suffer secondary complications from the
Type 2 diabetes and how he finally recovered. Get his full story by
logging into the VitalCare website at www.vitalcaretechnology.com
and follow the link to “Patient of the Month”.
In an effort to provide a resource for those seeking to better determine
if iCAT Therapy is a treatment option and to find out where the closest
iCAT Therapy provider is, VitalCare will continually update its website
as a means of providing information, for both healthcare providers and
those with Type 1 or Type 2 diabetes.
About VitalCare Diabetes Treatment Centers, Inc.
VitalCare Diabetes Treatment Centers, Inc. is a company specializing in
providing Administrative, Marketing, Business Development, Strategic
Planning, Clinical Oversight and Clinical Management Services to the
Diabetes Healthcare Sector, with an emphasis in bringing "Cutting Edge"
medical devices and healthcare services direct to consumers, focusing on
the emerging and FDA approved, US and European Patented technology and
treatment intervention for treating Type 1 and Type 2 Diabetes known as
"Intracellular Activation Therapy (iCAT)." The World Health Organization
(WHO) estimates that more than 180 million people worldwide have
diabetes. According to the WHO, this number is likely to more than
double by 2030 with diabetes related deaths projected to increase by
more than 50% in the next 10 years without urgent action. The US Center
for Disease Control, 2005 National Diabetes Fact Sheet, reports the
total prevalence of Diabetes in the US for all ages is 20.8 million of
which 14.6 million are diagnosed and 6.2 million are undiagnosed.
Safe Harbor Statement: Forward-looking statements in this release
with respect to VitalCare Diabetes Treatment Centers, Inc.'s business,
financial condition and results of operations, as well as matters of
timing and the prospective terms of the transaction described are
subject to risks and uncertainties that could cause actual results to
differ materially from those expressed in the forward-looking
statements, including, but not limited to, certain delays beyond
VitalCare Diabetes Treatment Centers, Inc.'s control with respect to
market acceptance of their technology and/or products, whether financing
will be available, the effect of the application of acquisition
accounting policies as well as certain other risk factors which are and
may be detailed from time to time in VitalCare's filings with the
Securities and Exchange Commission.
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1QaWdnLUhvcnItRmFsdS1Qcm9mLVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.